Direct-to-Consumer Drugs: A Tool for Big Pharma’s Domination
thersbshow.substack.com
"We don't suffer from a drug deficiency." This is one of Robert Scott Bell’s key arguments during his recent commentary on a Forbes article discussing the shift toward direct-to-consumer (DTC) drug sales by pharmaceutical giants like Pfizer and Eli Lilly.
Direct-to-Consumer Drugs: A Tool for Big Pharma’s Domination
Direct-to-Consumer Drugs: A Tool for Big…
Direct-to-Consumer Drugs: A Tool for Big Pharma’s Domination
"We don't suffer from a drug deficiency." This is one of Robert Scott Bell’s key arguments during his recent commentary on a Forbes article discussing the shift toward direct-to-consumer (DTC) drug sales by pharmaceutical giants like Pfizer and Eli Lilly.